Home > Healthcare > Biotechnology > Biopharma > pharmacogenomics market
Get a free sample of Pharmacogenomics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Pharmacogenomics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The pharmacogenomics industry is characterized by intense competition, with companies focusing on innovation, product differentiation, and strategic collaborations to gain a competitive edge. Growing adoption of pharmacogenomics in clinical practice, coupled with advancements in genomic technologies and increasing investment in research and development, is expected to drive further competition and innovation in the market. Overall, the market presents lucrative opportunities for companies to capitalize on the growing demand for personalized medicine and genetic testing in healthcare.
Prominent players operating in the pharmacogenomics industry include:
The market size of pharmacogenomics reached USD 3.3 billion in 2023 and is set to witness 10.5% CAGR during 2024-2032, led by increasing demand for precision medicine and advancements in genomic technologies.
North America market size was valued at USD 1.3 billion in 2023 and is anticipated to grow at 10.4% CAGR during 2024-2032, owing to robust healthcare infrastructure, with advanced research facilities and leading academic institutions.
The kits & reagents offering segment recorded USD 2 billion in 2023, as they offer a diverse portfolio of products tailored to different pharmacogenomics applications and technologies.
Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Charles River Laboratories, Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd, and Illumina Inc. among others.